Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

CCL Industries Announces Bolt on Transaction for CCL Label in Brazil

CCL Industries Inc., a world leader in specialty label and packaging solutions for global corporations, small businesses and consumers, announced today that it has acquired the assets of Powerpress Rotulos & Etiquetas Adesivas LTDA, Brazil's leading producer of expanded content labels for agricultural chemical and pharmaceutical customers.

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

Based in Sao Paolo, privately owned Powerpress had 2015 sales of approximately $6.5 million and an adjusted EBITDA of $2.5 million. Purchase price consideration is estimated at $10.25 million and is subject to certain customary completion adjustments.

Geoffrey T. Martin, President & CEO of CCL commented, "We have been in Brazil for 10 years where our CCL Label operation remains one of the best performing business units in the Company. Despite the changed economic climate in the country we believe now is a good time to make strategic investments to broaden our market presence. Powerpress will be immediately integrated into CCL Label Brazil led by Luis Jocionis, Vice President & Managing Director."

Videos from CCL Healthcare
Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?